These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10855364)

  • 1. The use of G-CSF in normal neutrophil donors.
    Price TH
    Ann Med Interne (Paris); 2000 Mar; 151(2):115-22. PubMed ID: 10855364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
    Hübel K; Dale DC; Engert A; Liles WC
    J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte transfusion: current status.
    Price TH
    Semin Hematol; 2007 Jan; 44(1):15-23. PubMed ID: 17198843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte transfusions in the G-CSF era. Where do we stand?
    Robinson SP; Marks DI
    Bone Marrow Transplant; 2004 Nov; 34(10):839-46. PubMed ID: 15273712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
    Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte-colony-stimulating factor.
    Hubel K; Rodger E; Gaviria JM; Price TH; Dale DC; Liles WC
    Transfusion; 2005 Dec; 45(12):1876-89. PubMed ID: 16371040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
    Heuft HG; Goudeva L; Blasczyk R
    Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collection of two consecutive neutrophil concentrates for transfusion from donors mobilized with glycosylated granulocyte-CSF plus dexamethasone.
    Heuft HG; Goudeva L; Schwella N; Blasczyk R
    Transfusion; 2004 May; 44(5):750-7. PubMed ID: 15104658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current prospects for neutrophil transfusions for the treatment of granulocytopenic infected patients.
    Price TH
    Transfus Med Rev; 2000 Jan; 14(1):2-11. PubMed ID: 10669936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained elevation of neutrophils in rats induced by lentivirus-mediated G-CSF delivery.
    Barry S; Brzezinski M; Yanay O; Seppen JE; Osborne WR
    J Gene Med; 2005 Dec; 7(12):1510-6. PubMed ID: 16041689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
    Heuft HG; Goudeva L; Pulver N; Grigull L; Schwella N; Blasczyk R
    Transfusion; 2005 Apr; 45(4):604-12. PubMed ID: 15819683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions.
    Price TH
    Curr Opin Hematol; 1998 Nov; 5(6):391-5. PubMed ID: 9814645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantation.
    Schwabe M; Hartert AM; Bertz H; Finke J
    Eur J Clin Invest; 2004 Nov; 34(11):759-65. PubMed ID: 15530149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of granulocyte/neutrophil transfusions for haematology/oncology patients in the modern era.
    Strauss RG
    Br J Haematol; 2012 Aug; 158(3):299-306. PubMed ID: 22712550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.